Carcinosarcome ovarien: A propos d'un cas

Ovarian carcinosarcoma also known as mixed mesodermal tumor or mixed Mullerian tumor is a rare gynecological tumor that accounts for less than 2% of ovarian cancers. It is an aggressive tumor which combines a carcinomatous component with a sarcomatous component. In the genital tract, it most often s...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of innovation and applied studies Vol. 30; no. 1; pp. 298 - 302
Main Authors Bendriss, I, El Mzabri, Z, El Youssfi, M, Bargach, S
Format Journal Article
LanguageFrench
Published Rabat International Journal of Innovation and Applied Studies 01.07.2020
Subjects
Cancer
Chemotherapy
Diagnostic systems
Ovaries
Survival
Tumors
Uterus
Online AccessGet full text

Cover

More Information
Summary:Ovarian carcinosarcoma also known as mixed mesodermal tumor or mixed Mullerian tumor is a rare gynecological tumor that accounts for less than 2% of ovarian cancers. It is an aggressive tumor which combines a carcinomatous component with a sarcomatous component. In the genital tract, it most often sits in the uterus. The ovary, cervix or vagina are more rarely affected. Carcinosarcoma interests women rather between 60 and 70 years of age. The main prognostic factor found is the initial stage, most often advanced: At diagnosis, more than 90% of ovarian carcinosarcomas have an extra-ovarian extension. Surgical management is a determining factor for the survival of patients. Carcinosarcoma is an aggressive tumor, the median survival is 7 to 27 months for ovarian carcinosarcomas. Relapses mainly occur in the first year. The FIGO stage is the most important prognostic factor.
ISSN:2028-9324